osteochondrodysplasia
osteochondrodysplasia
Explore linked clinical trials. Standard reference: MONDO:000551695 results · Page 1 of 4
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RCDP Natural History Study | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, Peroxisomal Disorders, bone disorder, chondrodysplasia punctata, hereditary disease, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, osteochondrodysplasia, rhizomelic chondrodysplasia punctata | Recruiting | Not stated | 2026-10-09 | NCT04031287 | |
| Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome | Bone Diseases, Developmental, bone disorder, fibrous dysplasia, musculoskeletal system disorder, osteochondrodysplasia, polyostotic fibrous dysplasia | Recruiting | Not stated | 2026-10-09 | NCT00001727 | |
| Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study） | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia | Active, not recruiting | Phase 3 | 2026-10-08 | NCT06926491 | |
| Setrusumab vs Placebo for Osteogenesis Imperfecta | Bone Diseases, Developmental, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta | Active, not recruiting | Phase 2 / Phase 3 | 2026-10-06 | NCT05125809 | |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC | Bone Diseases, Developmental, Camurati-Engelmann disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, bone disorder, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, hereditary disease, laryngeal disorder, musculoskeletal system disorder, neoplasm, osteochondrodysplasia, otorhinolaryngologic disease, respiratory system disorder, squamous cell carcinoma | Recruiting | Phase 2 / Phase 3 | 2026-10-02 | NCT06788990 | |
| Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease | Bone Diseases, Developmental, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, hyperostosis, musculoskeletal system disorder, osteochondrodysplasia, osteosclerosis, rheumatic disorder | Recruiting | Not stated | 2026-10-02 | NCT02504879 | |
| Natural History and Genetics of Food Allergy and Related Conditions | Abnormalities, Multiple, Aneurysm, Bone Diseases, Developmental, Camurati-Engelmann disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Loeys-Dietz syndrome, Musculoskeletal Abnormalities, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, aortic aneurysm, aortic disorder, atopic eczema, bone disorder, cardiovascular disorder, dermatitis, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, food allergy, gastroenteritis, hematologic disorder, hereditary disease, hereditary skin disorder, immune system disorder, leukocyte disorder, musculoskeletal system disorder, osteochondrodysplasia, skin disorder, vascular disorder | Recruiting | Not stated | 2026-10-02 | NCT02504853 | |
| A Study of TYRA-300 in Children With Achondroplasia: BEACH301 | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia | Recruiting | Phase 2 | 2026-10-01 | NCT06842355 | |
| Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Enchondromatosis, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, chondroma, chondrosarcoma, connective tissue disorder, connective tissue neoplasm, cutaneous mucinosis, hemangioma, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, neoplasm, osteochondrodysplasia, sarcoma, vascular cancer | Recruiting | Not stated | 2026-10-01 | NCT06749366 | |
| Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta | Bone Diseases, Developmental, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta | Active, not recruiting | Phase 3 | 2026-09-28 | NCT06636071 | |
| Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia | Recruiting | Phase 2 / Phase 3 | 2026-09-24 | NCT07441876 | |
| Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, hereditary disease, hypochondroplasia, musculoskeletal system disorder, osteochondrodysplasia | Recruiting | Not stated | 2026-09-23 | NCT07388966 | |
| A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR) | Bone Diseases, Developmental, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta | Recruiting | Phase 2 | 2026-09-22 | NCT07557446 | |
| The Role of Transforming Growth Factor- Beta (TGF- β) Expression in Renal Biopsy of Lupus Nephritis Patients | Bone Diseases, Developmental, Camurati-Engelmann disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, bone disorder, connective tissue disorder, glomerulonephritis, hereditary disease, immune system disorder, kidney disorder, lupus nephritis, musculoskeletal system disorder, nephritis, osteochondrodysplasia, systemic lupus erythematosus, urinary system disorder | Active, not recruiting | Not applicable | 2026-09-16 | NCT07823556 | |
| A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC | Bone Diseases, Developmental, Camurati-Engelmann disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, bone disorder, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, hereditary disease, laryngeal disorder, musculoskeletal system disorder, neoplasm, osteochondrodysplasia, otorhinolaryngologic disease, respiratory system disorder, squamous cell carcinoma | Recruiting | Phase 2 | 2026-09-08 | NCT07807163 | |
| BBD Longitudinal Study of Osteogenesis Imperfecta | Bone Diseases, Developmental, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, bone disorder, brittle bone disorder, connective tissue disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta, osteogenesis imperfecta type 5 | Recruiting | Not stated | 2026-09-01 | NCT02432625 | |
| Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hypochondroplasia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia | Enrolling by invitation | Phase 2 | 2026-08-26 | NCT07393373 | |
| Clear Aligners for the Treatment of Dental Malocclusion in OI | Bone Diseases, Developmental, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta | Active, not recruiting | Not applicable | 2026-08-18 | NCT04815564 | |
| Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN) | Bone Diseases, Developmental, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta | Recruiting | Phase 2 | 2026-08-17 | NCT07062588 | |
| A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, endocrine system disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia | Enrolling by invitation | Phase 2 / Phase 3 | 2026-08-17 | NCT05929807 | |
| InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer | Barrett esophagus, Bone Diseases, Developmental, Carcinoma, Lobular, Digestive System Diseases, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Genital Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Nevus, Pigmented, Osteochondroma, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, adenocarcinoma, bone disorder, breast disorder, breast neoplasm, carcinoma, cirrhosis of liver, connective tissue neoplasm, digestive system disorder, epithelial neoplasm, esophageal disorder, fatty liver disease, female reproductive system disorder, giant cell tumor, hematologic disorder, hematopoietic and lymphoid system neoplasm, in situ carcinoma, liver disorder, lung cancer, lung disorder, lung neoplasm, melanocytic neoplasm, melanocytic nevus, metabolic dysfunction-associated steatotic liver disease, mixed epithelioid and spindle cell melanoma, musculoskeletal system disorder, neoplasm, osteochondrodysplasia, pigmented spindle cell nevus, precancerous condition, respiratory system disorder, respiratory tract neoplasm, skin disorder, uterine disorder, vulvar intraepithelial neoplasia | Recruiting | Not stated | 2026-08-17 | NCT05463796 | |
| Rhizomelic Chondrodysplasia Punctata Registry | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, Peroxisomal Disorders, bone disorder, chondrodysplasia punctata, hereditary disease, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, osteochondrodysplasia, rhizomelic chondrodysplasia punctata, rhizomelic chondrodysplasia punctata type 1, rhizomelic chondrodysplasia punctata type 2, rhizomelic chondrodysplasia punctata type 3, rhizomelic chondrodysplasia punctata type 5 | Recruiting | Not stated | 2026-08-07 | NCT04569162 | |
| An Interventional Study of Infigratinib in Children With Hypochondroplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hypochondroplasia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia | Enrolling by invitation | Phase 2 / Phase 3 | 2026-07-16 | NCT06873035 | |
| Prospective Clinical Assessment Study in Children With Hypochondroplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hypochondroplasia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia | Recruiting | Not stated | 2026-07-16 | NCT06410976 | |
| Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, achondroplasia, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hereditary endocrine growth disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia | Recruiting | Phase 2 | 2026-07-13 | NCT07169279 |